Evidence map›Paper›PMID 18164625›Full record

ArticleProtein expression and purification2008

Expression and purification of BmrI restriction endonuclease and its N-terminal cleavage domain variants.

Yongming Bao, Lauren Higgins, Penghua Zhang, Siu-Hong Chan, Sophie Laget, Suzanne Sweeney, Keith Lunnen, Shuang-Yong Xu

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yongming BaoNew England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, USA.
Lauren Higgins
Penghua Zhang
Siu-Hong Chan
Sophie Laget
Suzanne Sweeney
Keith Lunnen
Shuang-Yong Xu
New England Biolabs (United States) · US

Funding

Engineering DNA nicking endonucleasesR42HG003976 · NHGRI · NEW ENGLAND BIOLABS, INC. · PI XU, SHUANG-YONG · 2005 to 2006
$568k
Cloning and Engineering of Nicking enzymesR41GM070212 · NIGMS · NEW ENGLAND BIOLABS, INC. · PI XU, SHUANG-YONG · 2004 to 2004
$104k
A Genetic System Able to Screen for Active DNA DemethylationR43GM077781 · NIGMS · NEW ENGLAND BIOLABS, INC. · PI XU, SHUANG-YONG · 2006 to 2006
$104k
A universal DNA endonucleaseR43GM073345 · NIGMS · NEW ENGLAND BIOLABS, INC. · PI XU, SHUANG-YONG · 2005 to 2005
$100k
NHGRI NIH HHS R42 HG003976NIGMS NIH HHS 1R43 GM073345-01NIGMS NIH HHS R41 GM070212NIGMS NIH HHS R43 GM073345NIGMS NIH HHS R43 GM077781
6 · The paper itself

Abstract

BmrI (ACTGGG N5/N4) is one of the few metal-independent restriction endonucleases (REases) found in bacteria. The BmrI restriction-modification system was cloned by the methylase selection method, inverse PCR, and PCR. BmrI REase shows significant amino acid sequence identity to BfiI and a putative endonuclease MspBNCORF3798 from the sequenced Mesorhizobium sp. BNC1 genome. The EDTA-resistant BmrI REase was successfully over-expressed in a pre-modified E. coli strain from pET21a or pBAC-expIQ vectors. The recombinant BmrI REase shows strong promiscuous activity (star activity) in NEB buffers 1, 4, and an EDTA buffer. Star activity was diminished in buffers with 100-150 mM NaCl and 10 mM MgCl(2). His-tagged BmrI192, the N-terminal cleavage domain of BmrI, was expressed in E. coli and purified from inclusion bodies. The refolded BmrI192 protein possesses non-specific endonuclease activity. BmrI192 variants with a single Ser to Cys substitution (S76C or S90C) and BmrI200 (T200C) with a single Cys at the C-terminal end were also constructed and purified. BmrI200 digests both single-strand (ss) and double-strand (ds) DNA and the nuclease activity on ss DNA is at least 5-fold higher than that on ds DNA. The Cys-containing BmrI192 and BmrI200 nuclease variants may be useful for coupling to other DNA binding elements such as synthetic zinc fingers, thio-containing locked nucleic acids (LNA) or peptide nucleic acids (PNA).

Indexed as

Deoxyribonucleases, Type II Site-SpecificAmino Acid SequenceBacillus megateriumCloning, MolecularDNA CleavageEscherichia coliGene ExpressionMolecular Sequence DataPlasmidsProtein Structure, TertiaryRecombinant Fusion ProteinsSOS Response, GeneticsTemperatureDeoxyribonucleases, Type II Site-SpecificRecombinant Fusion Proteins

Identifiers

PMID18164625
PMCPMC2275207
OpenAlexW2054405238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.